SCHEMBL5699733

SCHEMBL5699733

NC(=Cc1ccccc1)c1cccc2cc3ccccc3cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 5/20 0.57
GAA P10253 3/20 0.57
KMT2A Q03164 4/20 0.41
MAPT P10636 4/20 0.41
MEN1 O00255 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
AKR1C2 P52895 1/20 0.35
HPGD P15428 3/20 0.34
NR4A1 P22736 1/20 0.34
NR4A2 P43354 1/20 0.34
NR4A3 Q92570 1/20 0.34
RELA Q04206 1/20 0.34
GLA P06280 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922072 0.84 CYP1A2 (0.51) KDM4EGAAKMT2AMAPTSMN1; SMN2
SCHEMBL2256594 0.83 ALDH1A1 (0.41) KDM4EALDH1A1GAAKMT2AMAPT
SCHEMBL6422557 0.79 HPRT1 (0.45) ALDH1A1KMT2AMAPTCYP1A2CYP2C19
SCHEMBL1547491 0.79 KDM4E (0.47) KDM4EALDH1A1GAAKMT2AMAPT
SCHEMBL3868848 0.78 MCL1 (0.44) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL18543084 0.78 MCL1 (0.44) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL21786018 0.78 ALDH1A1 (0.46) KDM4EALDH1A1GAAKMT2AMAPT
SCHEMBL9098899 0.75 CYP1A2 (0.45) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL634215 0.73 KDM4E (1.00) KDM4EALDH1A1GAAKMT2AMAPT
SCHEMBL30181949 0.73 KDM4E (1.00) KDM4EALDH1A1GAAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 US claimed
US-6790975-B2 ORGANIC ELECTROLUMINESCENCE; CONDENSATION FROM A CORRESPONDING AMINOBENZALDEHYDE AND A PHOSPHONIC ESTER OR PHOSPHONIUM SALT; YELLOW TO RED LIGHT SONY CORPORATION (JP) 2004-09-14 US claimed
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-12-11 US claimed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 US claimed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 US claimed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 EP claimed
EP-2666059-A1 ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR, AND IMAGE FORMING METHOD, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE USING THE ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR Ricoh Company Ltd. (JP) 2013-11-27 EP disclosed
WO-2012099182-A1 ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR, AND IMAGE FORMING METHOD, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE USING THE ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR RICOH COMPANY, LTD. (JP) 2012-07-26 WO disclosed
EP-1090911-B1 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORP (JP) 2006-08-30 EP disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 US disclosed
US-7022868-B2 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-04-04 US disclosed
EP-1191015-A4 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH SONY CORP (JP) 2005-12-14 EP disclosed
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-11-06 US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 US disclosed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 US disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 EP disclosed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 EP disclosed
WO-2001077065-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH SONY CORPORATION (JP) 2001-10-18 WO disclosed
JP-2001288377-A AMINOSTYRYLANTHRACENE COMPOUND AND INTERMEDIATE FOR SYNTHESIZING THE SAME, AND METHOD FOR PRODUCING THESE COMPOUNDS SONY CORP 2001-10-16 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 KDM4E 2038/4885ALDH1A1 1220/4885GAA 3932/4885
US-20030229242-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 KDM4E 1749/4885ALDH1A1 847/4885GAA 3962/4885
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF AASDHPPT, AADAT, ALDH7A1 KDM4E 1749/4885ALDH1A1 847/4885GAA 3962/4885
US-20030208089-A1 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, ALDH7A1, AGPAT5 KDM4E 2103/4885ALDH1A1 1057/4885GAA 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.